PRESS-RELEASE ·Filed Mar 3, 2026
Press release · Earnings
Actionable Insight • Neutral
Traders should monitor the March 19 earnings call for actual financial results and management commentary, particularly revenue trends, cash runway, and updates on late-stage product candidates.
Final — all horizons settled through T+60d
ETON ▲ +81.75% at T+60d
NEUTRAL call +81.75% · α vs SPY +71.66% · entry $17.53 → $31.86
T+1d
-1.65%
call -1.65% · α -1.08%
$17.24
settled 8mo ago
T+5d
+3.19%
call +3.19% · α +4.53%
$18.09
settled 8mo ago
T+20d
+44.67%
call +44.67% · α +49.08%
$25.36
settled 7mo ago
T+60d
+81.75%
call +81.75% · α +71.66%
$31.86
settled 5mo ago
Price Chart
Loading chart...
Executive Summary
Eton Pharmaceuticals announced it will report its fourth quarter and full year 2025 financial results on March 19, 2026, followed by a conference call and webcast. The press release contains no actual financial data, only logistical details for the earnings announcement.
Key Facts
- Eton Pharmaceuticals will report Q4 and full year 2025 financial results on March 19, 2026.
- Management will host a conference call and live webcast at 4:30 p.m. ET.
- Investors can submit questions via email ahead of the call.
- No financial results, guidance, or operational updates were disclosed in this release.
Financial Impact
None disclosed — financial results not included in this release
Risk Factors
- Lack of disclosed financials limits ability to assess performance ahead of the call.
- Potential for negative reaction if results miss expectations or cash burn remains high.
Market Snapshot
Exchange
Nasdaq
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3248960 |
23 reports for ETON
75% Hit rate @ T+60 Went positive at some point 13 of 14 best @ T+60▲ +95.18%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 13d ago | 8-K | $52.88 | awaiting T+60 | — | $50.11 (−5.24%) |
Oct 6, 2026 20d ago | 144 | $54.88 | awaiting T+60 | — | $50.11 (−8.69%) |
Sep 28, 2026 29d ago | 8-K | $59.18 | awaiting T+60 | — | $50.11 (−15.33%) |
Aug 31, 2026 8w ago | Insider Cluster | $60.43 | awaiting T+60 | — | $50.11 (−17.08%) |
Aug 28, 2026 8w ago | Insider Cluster | $60.44 | awaiting T+60 | — | $50.11 (−17.09%) |
Aug 24, 2026 9w ago | Insider Cluster | $63.05 | awaiting T+60 | — | $50.11 (+20.52%) |
Aug 19, 2026 9w ago | 144 | $61.48 | awaiting T+60 | — | $50.11 (+18.49%) |
Aug 5, 2026 11w ago | 8-K | $45.97 | awaiting T+60 | — | $50.11 (+9.01%) |
Aug 5, 2026 11w ago | Press Release | $45.97 | awaiting T+60 | — | $50.11 (+9.01%) |
Aug 4, 2026 12w ago | 8-K | $45.83 | awaiting T+60 | — | $50.11 (+9.34%) |
Showing 10 of 23
US Market Status
Market Open — Closes in 3h 42m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers